@AlisonBFierce: Inovio Pharmaceuticals, a developer of synthetic vaccines, expanded its existing license agreement with UPenn. More | Follow @AlisonBFierce > Vaccibody landed a €2 million ...

Vietnam has made remarkable progress in protecting children from vaccine-preventable diseases, according to the latest World ...

French pharmaceutical company Sanofi said on Tuesday it was exploring opportunities for producing vaccines in Vietnam in cooperation with local partner Vietnam Vaccine Company (VNVC), which announced ...

Investing.com -- Sanofi (EPA: SASY) (NASDAQ: SNY), in collaboration with Vietnam Vaccine JSC (VNVC), launched a vaccine production facility in Vietnam on Tuesday. The manufacturing plant is designed ...

The launch was witnessed by French President Emmanuel Macron during his visit to the Southeast Asian country. The plant, situated in the southern province of Long An, spans 2.6 hectares (6.4 acres) ...

The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

Friendship is one of the most profound characteristics of the bilateral ties, forged over a long history full of ups and ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

Investing.com -- Sanofi (NASDAQ: SNY), in collaboration with Vietnam Vaccine JSC (VNVC), launched a vaccine production facility in Vietnam on Tuesday. The manufacturing plant is designed to ...

Sanofi agreed to buy UK vaccine developer Vicebio Ltd. for as much as $1.6 billion, as it seeks to expand in respiratory ...